secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emergent BioSolutions Inc. (EBS)
CIK:        0001367644
Form:       8-K
Filed at:   2024-07-30T23:59:59+00:00
Accession:  0001367644-24-000130
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Emergent BioSolutions EVP, General Counsel and Corporate Secretary Jennifer Fox resigns effective August 16, 2024
--------------------------------------------------------------------------------

- Jennifer Fox resigns as EVP External Affairs, General Counsel and Corporate Secretary to pursue an external opportunity.
- Her resignation is effective August 16, 2024; she will continue in her role until that date.
- No successor has been announced; CFO Richard S. Lindahl remains in place.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367644/000136764424000130/0001367644-24-000130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367644/000136764424000130/ebs-20240730.htm
  HTML page:      https://secwatch.observer/filing/0001367644-24-000130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer